您的购物车当前为空
别名 TL 13-22
TL13-22是一种高效的间变性淋巴瘤激酶(Anaplastic Lymphoma Kinase, ALK)抑制剂,其IC₅₀值为0.54 nM,并且不会导致ALK蛋白的降解。TL13-22常被用作TL13-12(诱导ALK蛋白降解)的阴性对照。TL13-22还能促使其他激酶降解,包括Aurora A、FER、PTK2和RPS6KA1。


为众多的药物研发团队赋能,
让新药发现更简单!
TL13-22是一种高效的间变性淋巴瘤激酶(Anaplastic Lymphoma Kinase, ALK)抑制剂,其IC₅₀值为0.54 nM,并且不会导致ALK蛋白的降解。TL13-22常被用作TL13-12(诱导ALK蛋白降解)的阴性对照。TL13-22还能促使其他激酶降解,包括Aurora A、FER、PTK2和RPS6KA1。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 3,120 | In Stock | |
| 5 mg | ¥ 7,280 | In Stock | |
| 10 mg | ¥ 9,790 | In Stock | |
| 25 mg | ¥ 14,500 | In Stock | |
| 50 mg | ¥ 19,600 | In Stock |
TL13-22 相关产品
| 产品描述 | TL13-22 is a potent inhibitor of Anaplastic Lymphoma Kinase (ALK) with an IC₅₀ value of 0.54 nM and does not lead to degradation of ALK proteins.TL13-22 is often used as a negative control for TL13-12 (induces ALK protein degradation) as a negative control.TL13-22 also induces degradation of other kinases, including Aurora A, FER, PTK2, and RPS6KA1. |
| 靶点活性 | ALK:0.54 nM |
| 体外活性 | TL13-22促使Aurora A,FER,PTK2和RPS6KA1激酶降价的浓度分别为11.3,5.74,18.4和65.9 nM。[1] |
| 别名 | TL 13-22 |
| 分子量 | 947.5 |
| 分子式 | C45H55ClN10O9S |
| CAS No. | 2229036-65-9 |
| Smiles | O=C1C=2C=CC=C(NCC(=O)NCCOCCOCCN3CCN(C4=CC=C(NC5=NC=C(Cl)C(=N5)NC=6C=CC=CC6S(=O)(=O)C(C)C)C(OC)=C4)CC3)C2C(=O)N1C7C(=O)NCCC7 |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 200 mg/mL (211.08 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容